Huntington's Disease (HD) Terminated Phase 3 Trials for Latrepirdine (DB11725)

Also known as: Huntington's chorea / Huntington disease / Huntington's disease

IndicationStatusPhase
DBCOND0053941 (Huntington's Disease (HD))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01085266An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington DiseaseTreatment